Hypertrophy, Left Ventricular
"Hypertrophy, Left Ventricular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
Descriptor ID |
D017379
|
MeSH Number(s) |
C14.280.195.400 C23.300.775.250.400
|
Concept/Terms |
Hypertrophy, Left Ventricular- Hypertrophy, Left Ventricular
- Left Ventricular Hypertrophy
- Hypertrophies, Left Ventricular
- Left Ventricular Hypertrophies
- Ventricular Hypertrophies, Left
- Ventricular Hypertrophy, Left
|
Below are MeSH descriptors whose meaning is more general than "Hypertrophy, Left Ventricular".
Below are MeSH descriptors whose meaning is more specific than "Hypertrophy, Left Ventricular".
This graph shows the total number of publications written about "Hypertrophy, Left Ventricular" by people in this website by year, and whether "Hypertrophy, Left Ventricular" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
2002 | 3 | 0 | 3 |
2003 | 0 | 2 | 2 |
2004 | 2 | 1 | 3 |
2005 | 1 | 1 | 2 |
2006 | 2 | 2 | 4 |
2008 | 2 | 1 | 3 |
2009 | 1 | 0 | 1 |
2010 | 1 | 1 | 2 |
2011 | 1 | 3 | 4 |
2012 | 1 | 0 | 1 |
2013 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2015 | 2 | 0 | 2 |
2017 | 2 | 0 | 2 |
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypertrophy, Left Ventricular" by people in Profiles.
-
Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality. Cardiovasc Res. 2019 02 01; 115(2):395-408.
-
Left Ventricular Mass, Brain Magnetic Resonance Imaging, and Cognitive Performance: Results From the Strong Heart Study. Hypertension. 2017 11; 70(5):964-971.
-
Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study. Cardiovasc Diabetol. 2017 05 12; 16(1):64.
-
Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure. Heart. 2017 01 01; 103(1):49-54.
-
Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence. Cardiovasc Res. 2015 Jun 01; 106(3):421-31.
-
Effect of dietary sodium and potassium intake on left ventricular diastolic function and mass in adults=40 years (from the Strong Heart Study). Am J Cardiol. 2015 May 01; 115(9):1244-8.
-
Granule cargo release from bone marrow-derived cells sustains cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2014 Nov 15; 307(10):H1529-38.
-
Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. J Am Heart Assoc. 2013 Jun 06; 2(3):e000144.
-
Eosinophilic endocarditis and Strongyloides stercoralis. Am J Cardiol. 2013 Aug 01; 112(3):461-2.
-
Relative fat-free mass deficiency and left ventricular adaptation to obesity: the Strong Heart Study. Int J Cardiol. 2013 Sep 30; 168(2):729-33.